Thomas Harrington

May 1, 2023 | outsourcedpharma.com | Peter Alexander |Thomas Harrington |Ed White |Alok Tayi |Louis Garguilo

Article | By Alok Tayi, Ph.D., Egnyte Drug development has dramatically changed over the past ten years. A practice once dominated by pen and paper has since been overrun by computerized systems, cloud software, and artificial intelligence. In this piece, we will chronicle recent technological trends, specific challenges these trends pose for quality and CSV teams, and best practices for tackling resulting compliance issues.

May 1, 2023 | outsourcedpharma.com | Peter Alexander |Thomas Harrington |Ed White |Alok Tayi |Louis Garguilo

Article | By Alok Tayi, Ph.D., Egnyte Drug development has dramatically changed over the past ten years. A practice once dominated by pen and paper has since been overrun by computerized systems, cloud software, and artificial intelligence. In this piece, we will chronicle recent technological trends, specific challenges these trends pose for quality and CSV teams, and best practices for tackling resulting compliance issues.